Pharma
2023: a new year with a renewed focus for the Guardtech Group
Cleanroom construction specialists’ multi-faceted approach set to reach new levels and new audiences in 2023. ...
Spatial lung cell atlas offers insights into disease and immune function
The most comprehensive lung cell atlas to date, from the Wellcome Sanger Institute and collaborators, has revealed 11 new lung cell types and offers detailed insight into an immune process involved in fighting lung infections. ...
EPSRC-funded software for research communities project to position OpenMM community at forefront of latest CADD developments
A recent EPSRC application in support of a more sustainable, community-driven development model of OpenMM. ...
Cresset shares December 2022 newsletter
The Cresset December 2022 newsletter features Dr Robert Scoffin's CEO end of year message, and radial plots in Flare and Spark. ...
CCDC Webinar: The CSD Data Curation Process
The Cambridge Structural Database (CSD) contains over 1.2M experimental 3D structures with data from X-ray and neutron diffraction analyses. Researchers across the pharmaceutical, agrochemical and fine chemical industries use the database to predict and guide future discoveries. It’s a ...
Guardtech Group December Wrap-Up: a year of huge growth, joy and goodwill to all
As 2022 comes to a close, cleanroom construction specialists Guardtech joyously celebrate their busiest ever year. ...
Anne Glover and Hermann Hauser, reflecting on 25 years of Amadeus Capital Partners
As Amadeus celebrates 25 years since it was founded, Partner Amelia Armour sits down with Hermann Hauser and Anne Glover to reflect on the past three decades in our latest podcast episode. ...
Leading UK Diagnostics provider Source LDPath expands AI capabilities with Ibex Medical Analytics
NHS Trusts Gain Access to Galen, Ibex's Multi-tissue AI Platform, Supporting Pathologists with Enhanced Diagnostic Accuracy and Efficiency ...
Metrion Biosciences and The KCNC1 Foundation collaborate on development of new ion channel modulators for ultra-rare genetic disorder
Research targeted at identifying novel inhibitors or activators of Kv3.1 mutation ...
Klebsiella pneumoniae vaccines - time to reprioritize
This month VacZine Analytics, a UK-based strategic research publisher exclusively focused on vaccines and infectious diseases, releases a brand-new global forecast of new Klebsiella pneumoniae vaccines. ...